RedHill (RDHL) Shares Surged On Promising Regulatory News
RedHill Biopharma Ltd. (NASDAQ: RDHL) drew strong investor interest in the previous trading session following a significant regulatory update. That resulted in a 26.34% rise in RDHL stock price causing it to close the session at $2.35. FDA Supports First-Ever MAP-Positive CD Trial RedHill announced encouraging feedback from the U.S. Food and Drug Administration (FDA) […]